Literature DB >> 3856886

One hundred base pairs of 5' flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription.

C Bertholet, R Drillien, R Wittek.   

Abstract

A vaccinia virus late gene coding for a major structural polypeptide of 11 kDa was sequenced. Although the 5' flanking gene region is very A+T rich, it shows little homology either to the corresponding region of vaccinia early genes or to consensus sequences characteristic of most eukaryotic genes. Three DNA fragments (100, 200, and 500 base pairs, respectively), derived from the flanking region and including the late gene mRNA start site, were inserted into the coding sequence of the vaccinia virus thymidine kinase (TK) early gene by homologous in vivo recombination. Recombinants were selected on the basis of their TK- phenotype. Cells were infected with the recombinant viruses and RNA was isolated at 1-hr intervals. Transcripts initiating either from the TK early promoter, or from the late gene promoter at its authentic position, or from the translocated late gene promoters within the early gene were detected by nuclease S1 mapping. Early after infection, only transcripts from the TK early promoter were detected. Later in infection, however, transcripts were also initiated from the translocated late promoters. This RNA appeared at the same time and in similar quantities as the RNA from the late promoter at its authentic position. No quantitative differences in promoter efficiency between the 100-, 200-, and 500-base-pair insertions were observed. We conclude that all necessary signals for correct regulation of late-gene expression reside within only 100 base pairs of 5' flanking sequence.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3856886      PMCID: PMC397499          DOI: 10.1073/pnas.82.7.2096

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs.

Authors:  J A Cooper; R Wittek; B Moss
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

2.  Fine structure analysis and nucleotide sequence of the vaccinia virus thymidine kinase gene.

Authors:  D E Hruby; R A Maki; D B Miller; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

3.  Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.

Authors:  G L Smith; M Mackett; B Moss
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

4.  Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition.

Authors:  S Venkatesan; A Gershowitz; B Moss
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

5.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

Review 6.  Organization and expression of the poxvirus genome.

Authors:  R Wittek
Journal:  Experientia       Date:  1982-03-15

7.  Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Authors:  D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Nucleotide sequence of the vaccinia virus thymidine kinase gene and the nature of spontaneous frameshift mutations.

Authors:  J P Weir; B Moss
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

9.  Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.

Authors:  D Panicali; S W Davis; R L Weinberg; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

10.  A phosphorylated basic vaccinia virion polypeptide of molecular weight 11,000 is exposed on the surface of mature particles and interacts with actin-containing cytoskeletal elements.

Authors:  G Hiller; K Weber
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

View more
  61 in total

1.  Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases.

Authors:  G L Smith; Y S Chan; S M Kerr
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

2.  Genetic evidence for involvement of vaccinia virus DNA-dependent ATPase I in intermediate and late gene expression.

Authors:  M S Künzi; P Traktman
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression.

Authors:  W F McDonald; V Crozel-Goudot; P Traktman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Transient dominant selection of recombinant vaccinia viruses.

Authors:  F G Falkner; B Moss
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  High expression of functional adenovirus DNA polymerase and precursor terminal protein using recombinant vaccinia virus.

Authors:  H G Stunnenberg; H Lange; L Philipson; R T van Miltenburg; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

7.  In vitro synthesis of vaccinia virus late mRNA containing a 5' poly(A) leader sequence.

Authors:  C F Wright; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  pUV I: a new vaccinia virus insertion and expression vector.

Authors:  F G Falkner; S Chakrabarti; B Moss
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

9.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

10.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.